This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Vestar, Inc.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Paula J. Konigsberg
Introduction
Paula J. Konigsberg is a notable inventor based in Pasadena, CA, recognized for her significant contributions to the field of biomedical engineering. She has developed innovative solutions that enhance the delivery of therapeutic agents, particularly in the treatment of immune system disorders.
Latest Patents
One of her key patents is titled "Liposome targeting using receptor specific ligands." This patent describes delivery vehicle formulations that comprise active agents encapsulated within liposomal vesicles. These vesicles are attached to protein hormones, known as ligands, such as interleukin-2. The ligands exhibit affinity for specific cell receptors, facilitating the targeted delivery of encapsulated active agents to particular cell populations. This innovation is crucial for improving treatment outcomes in various immune system disorders. Paula holds 1 patent in this area.
Career Highlights
Throughout her career, Paula has worked with several prominent companies, including Vestar, Inc. and Isogenis, Inc. Her work in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in drug delivery systems.
Collaborations
Paula has collaborated with esteemed colleagues, including LeRoy L. Richer and Paul G. Schmidt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Paula J. Konigsberg's contributions to the field of biomedical engineering, particularly through her innovative patent on liposome targeting, highlight her role as a leading inventor. Her work continues to influence the development of targeted therapies for immune system disorders, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile